Abstract
Accepted 18 March 1997
DNA from 46 unrelated patients with Gaucher's disease was analysed for 10 known mutations: 84GG(c84 G 85ins), N370S (c1226G), L444P (c1448C), R463C (c1504T), R496H (c1604A), IVS2+1, D409H (c1342C), RecNciI (c1448C-1498C), RecTL (c1342C-1498C), and c1263del (c1264-1318del). Fifty four mutations (90%) were identified in 30 patients with type I disease. These included a previously undescribed recombinant mutation RecA456P (c1448C-1484C). Thirteen (54%) of 24 type II alleles were identified, including one new point mutation N462K (c1503G) and one new 55bp deletion also incorporating the RecTL mutations c1263del+RecTL (c1264del-1498C). All four type III patients were homozygous for the L444P point mutation. Generally, patients with one copy of the N370S mutation had mild adult onset disease, regardless of the nature of their second mutation. Three exceptions had childhood onset disease and genotypes N370S/R463C, N370S/RecA456P, and N370S/?. The L444P/L444P genotype was thought to be associated with neurological disease. Two type I patients with this genotype who exhibited no central nervous system disease were identified, however. The R463C and c1263del mutations were found to be present at a higher frequency than reported in other populations and they should be included in any mutation screen of this population. The recombinant mutations RecA456P and c1263del+RecTL have not been previously described and are the fourth and fifth recombinant mutations identified in the glucocerebrosidase gene.
Full Text
The Full Text of this article is available as a PDF (175.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abrahamov A., Elstein D., Gross-Tsur V., Farber B., Glaser Y., Hadas-Halpern I., Ronen S., Tafakjdi M., Horowitz M., Zimran A. Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype. Lancet. 1995 Oct 14;346(8981):1000–1003. doi: 10.1016/s0140-6736(95)91688-1. [DOI] [PubMed] [Google Scholar]
- Beutler E. Gaucher disease: new molecular approaches to diagnosis and treatment. Science. 1992 May 8;256(5058):794–799. doi: 10.1126/science.1589760. [DOI] [PubMed] [Google Scholar]
- Beutler E., Gelbart T. Erroneous assignment of Gaucher disease genotype as a consequence of a complete gene deletion. Hum Mutat. 1994;4(3):212–216. doi: 10.1002/humu.1380040307. [DOI] [PubMed] [Google Scholar]
- Beutler E., Gelbart T. Glucocerebrosidase (Gaucher disease). Hum Mutat. 1996;8(3):207–213. doi: 10.1002/(SICI)1098-1004(1996)8:3<207::AID-HUMU2>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
- Beutler E., Gelbart T., Kuhl W., Zimran A., West C. Mutations in Jewish patients with Gaucher disease. Blood. 1992 Apr 1;79(7):1662–1666. [PubMed] [Google Scholar]
- Beutler E., Gelbart T., West C. Identification of six new Gaucher disease mutations. Genomics. 1993 Jan;15(1):203–205. doi: 10.1006/geno.1993.1035. [DOI] [PubMed] [Google Scholar]
- Horowitz M., Tzuri G., Eyal N., Berebi A., Kolodny E. H., Brady R. O., Barton N. W., Abrahamov A., Zimran A. Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patients. Am J Hum Genet. 1993 Oct;53(4):921–930. [PMC free article] [PubMed] [Google Scholar]
- Horowitz M., Wilder S., Horowitz Z., Reiner O., Gelbart T., Beutler E. The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics. 1989 Jan;4(1):87–96. doi: 10.1016/0888-7543(89)90319-4. [DOI] [PubMed] [Google Scholar]
- Kawame H., Maekawa K., Eto Y. Molecular screening of Japanese patients with Gaucher disease: phenotypic variability in the same genotypes. Hum Mutat. 1993;2(5):362–367. doi: 10.1002/humu.1380020507. [DOI] [PubMed] [Google Scholar]
- Latham T., Grabowski G. A., Theophilus B. D., Smith F. I. Complex alleles of the acid beta-glucosidase gene in Gaucher disease. Am J Hum Genet. 1990 Jul;47(1):79–86. [PMC free article] [PubMed] [Google Scholar]
- Mistry P. K., Cox T. M. The glucocerebrosidase locus in Gaucher's disease: molecular analysis of a lysosomal enzyme. J Med Genet. 1993 Nov;30(11):889–894. doi: 10.1136/jmg.30.11.889. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Newton C. R., Graham A., Heptinstall L. E., Powell S. J., Summers C., Kalsheker N., Smith J. C., Markham A. F. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 1989 Apr 11;17(7):2503–2516. doi: 10.1093/nar/17.7.2503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peters S. P., Lee R. E., Glew R. H. A microassay for Gaucher's disease. Clin Chim Acta. 1975 May 1;60(3):391–396. doi: 10.1016/0009-8981(75)90083-2. [DOI] [PubMed] [Google Scholar]
- Sidransky E., Bottler A., Stubblefield B., Ginns E. I. DNA mutational analysis of type 1 and type 3 Gaucher patients: how well do mutations predict phenotype? Hum Mutat. 1994;3(1):25–28. doi: 10.1002/humu.1380030105. [DOI] [PubMed] [Google Scholar]
- Walley A. J., Barth M. L., Ellis I., Fensom A. H., Harris A. Gaucher's disease in the United Kingdom: screening non-Jewish patients for the two common mutations. J Med Genet. 1993 Apr;30(4):280–283. doi: 10.1136/jmg.30.4.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zimran A., Gelbart T., Westwood B., Grabowski G. A., Beutler E. High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews. Am J Hum Genet. 1991 Oct;49(4):855–859. [PMC free article] [PubMed] [Google Scholar]
- Zimran A., Sorge J., Gross E., Kubitz M., West C., Beutler E. A glucocerebrosidase fusion gene in Gaucher disease. Implications for the molecular anatomy, pathogenesis, and diagnosis of this disorder. J Clin Invest. 1990 Jan;85(1):219–222. doi: 10.1172/JCI114415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zimran A., Sorge J., Gross E., Kubitz M., West C., Beutler E. Prediction of severity of Gaucher's disease by identification of mutations at DNA level. Lancet. 1989 Aug 12;2(8659):349–352. doi: 10.1016/s0140-6736(89)90536-9. [DOI] [PubMed] [Google Scholar]